Cargando…
ERCC1 and MGMT Methylation as a Predictive Marker of Relapse and FOLFOX Response in Colorectal Cancer Patients from South Tunisia
Genetic and epigenetic modifications present a major cause of relapse and treatment failure in colorectal cancer. This study aims to appreciate the prognostic and predictive value of ERRC1 and MGMT methylation. We also studied the prognostic impact of the ERCC1 rs11615 polymorphism as well as its ex...
Autores principales: | Jamai, Dhouha, Gargouri, Raja, Selmi, Boulbaba, Khabir, Abdelmajid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10379058/ https://www.ncbi.nlm.nih.gov/pubmed/37510370 http://dx.doi.org/10.3390/genes14071467 |
Ejemplares similares
-
Characteristics of epstein barr virus variants associated with gastric carcinoma in Southern Tunisia
por: BenAyed-Guerfali, Dorra, et al.
Publicado: (2011) -
ERCC1 as a Predictive Marker for FOLFOX Chemotherapy in an Adjuvant Setting
por: Kim, Chee Young, et al.
Publicado: (2015) -
Identification of a Novel Methylated Gene in Nasopharyngeal Carcinoma: TTC40
por: Ayadi, Wajdi, et al.
Publicado: (2014) -
Quantitative expression analysis and prognostic significance of the BCL2-associated X gene in nasopharyngeal carcinoma: a retrospective cohort study
por: Kontos, Christos K, et al.
Publicado: (2013) -
Association between MGMT Enhancer Methylation and MGMT Promoter Methylation, MGMT Protein Expression, and Overall Survival in Glioblastoma
por: Zappe, Katja, et al.
Publicado: (2023)